High-affinity T cell receptors for adoptive cell transfer

被引：3

作者：

Isser, Ariel ^{[1
]}

Schneck, Jonathan P. ^{[2
,3
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA

[2] Johns Hopkins Univ, Sch Med, Dept Pathol Med & Oncol, Baltimore, MD 21205 USA

[3] Johns Hopkins Univ, Sch Med, Immunol Program, Inst Cellular Engn, Baltimore, MD 21205 USA

来源：

JOURNAL OF CLINICAL INVESTIGATION | 2019年 / 129卷 / 01期

基金：

美国国家科学基金会;

关键词：

CANCER REGRESSION; GENE-THERAPY; ANTIGEN; CD4(+); MELANOMA; IMMUNITY; MICE;

D O I：

10.1172/JCI125471

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Adoptive cell transfer (ACT) of engineered T cell receptors (TCRs) for cancer immunotherapy has evolved from simple gene transfer of isolated TCRs to various affinity enhancement techniques that overcome limitations imposed by central and peripheral tolerance on TCR affinity. In the current issue of the JCI, Poncette et al. used mice with human TCR alpha beta and HLA gene loci to discover CD4(+) TCRs of optimal affinity for cancer testis antigen (CTA) NY-ESO-1. They combined this TCR with a previously discovered NY-ESO-1-specific CD8(+) TCR in an ACT fibrosarcoma tumor model to demonstrate the importance of T cell help in mediating antitumor responses.

引用

页码：69 / 71

页数：3

共 50 条

[31] Developing High-Affinity Boron-Based Receptors for Cell-Surface Carbohydrates
Houston, Todd A.
CHEMBIOCHEM, 2010, 11 (07) : 954 - 957
[32] Establishing T cell memory by adoptive transfer of T cell clones.
Berger, Carolina
Jensen, Michael C.
Riddell, Stanley R.
BLOOD, 2006, 108 (11) : 259A - 260A
[33] High-affinity small molecule inhibitors of T cell costimulation: Compounds for immunotherapy
Huxley, P
Sutton, DH
Debnam, P
Matthews, IR
Brewer, JE
Rose, J
Trickett, M
Williams, DD
Andersen, TB
Classon, BJ
CHEMISTRY & BIOLOGY, 2004, 11 (12): : 1651 - 1658
[34] SELECTING T-CELL RECEPTORS WITH HIGH-AFFINITY FOR SELF-MHC BY DECREASING THE CONTRIBUTION OF CD8
SHERMAN, LA
HESSE, SV
IRWIN, MJ
LAFACE, D
PETERSON, P
SCIENCE, 1992, 258 (5083) : 815 - 818
[35] Engineering high affinity, soluble T cell receptors for the treatment of cancer
Holt, L.
Liddy, N.
Bossi, G.
Harper, J.
Dukes, J.
Paston, S.
Mahon, T.
Molloy, P.
Sami, M.
Baston, E.
Cameron, B.
Powesland, A.
Johnson, A.
Hassan, N.
Vuidepot, A.
Coughlin, C.
Jakobsen, B.
EUROPEAN JOURNAL OF CANCER, 2018, 92 : S15 - S16
[36] Developing high affinity, soluble T cell receptors for the treatment of cancer
Knox, Andrew
Chester, Fiona
Bianchi, Frayne
Bailey, Sarah
Bouard, Lucie
Liddy, Nathaniel
Bossi, Giovanna
Harper, Jane
Dukes, Joseph
Paston, Samantha
Mahon, Tara
Gavarret, Jessie
Molloy, Peter
Sami, Malkit
Baston, Emma
Cameron, Brian
Powlesland, Alex
Todorov, Penio
Johnson, Andrew
Ebner, Martin
McGrath, Yvonne
Hassan, Namir
Vuidepot, Annelise
Jakobsen, Bent
CANCER RESEARCH, 2016, 76
[37] High-throughput method identifies rare, high-affinity, thymus-vetted T cell receptors (TCRs) for clinical translation
Schmitt, Thomas M.
McAfee, Megan
Robins, Harlan
Kropp, Lara
Greenberg, Philip D.
Chapuis, Aude G.
CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09)
[38] Programming T cells for adoptive T cell transfer therapy
Chapman, Paul B.
PIGMENT CELL & MELANOMA RESEARCH, 2010, 23 (02) : 155 - 156
[39] SOLUBILIZATION OF HIGH-AFFINITY DOPAMINE RECEPTORS
GORISSEN, H
LADURON, P
NATURE, 1979, 279 (5708) : 72 - 74
[40] Identification of EBV epitope-specific T cell receptors for adoptive T cell transfer against EBV infection and associated malignancies
Cobo, Lammoglia M. F.
Welters, C.
Pircher, C.
Gary, R.
Dietze, K.
Takvorian, A.
Penter, L.
Bullinger, L.
Dornmair, K.
Moosmann, A.
Mautner, J.
Blankenstein, T.
Kammertoens, T.
Gerbitz, A.
Hansmann, L.
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 239 - 239

← 1 2 3 4 5 →